SPIRIT HEALTH GROUP LTD

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -21.4%

  £17,567,513 → £13,813,494

• Cash

  +20%

  £32,349 → £38,824

  highest in 3 filed years

• Net assets

  -387.2%

  £782,731 → -£2,248,257

• Employees

  -53.1%

  192 → 90

• Operating profit

  -561.7%

  -£176,884 → -£1,170,529

• Profit before tax

  -448.1%

  -£546,575 → -£2,995,518

• Wages

  -23.3%

  £4,761,905 → £3,650,613

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. SPIRIT HEALTH GROUP LTD 2018-01-30 → present
2. SPIRIT INT LIMITED 2014-05-13 → 2018-01-30

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Nuvo Audit Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the group and parent company's ability to continue as a going concern.”

Group structure

1. SPIRIT HEALTH GROUP LTD · parent
   1. Spirit Healthcare Limited 100%
   2. Spirit Clinical Services Limited 100%
   3. Spirit Digital Limited 76%
   4. Spirit Implement Limited 51%
   5. Spirit Health Group EBT Limited 100%

Significant events

• “The turnover of the Group has declined year on year due to the disposal of our primary care business in the prior year. The underlying stability of our existing product base remains strong. We continue to strengthen our product proposition to support future growth and brought to market further new, cost competitive products across our diabetes range that offer cost saving opportunities for the NHS.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.